Key facts
- This page summarizes Fiona Sutherland's Form 4 filing for ACUREN CORP (TIC).
- 3 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 01 Aug 2025, 18:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Tax liability
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
On July 30, 2025, 10,000 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.
Footnote F2
Shares withheld for tax liability.
Footnote F3
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F4
These restricted stock units vest 33 1/3% on the first through third anniversaries of the grant date (July 30, 2024).
Footnote F5
Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F6
Subject to the volume weighted average price ("VWAP") of the Issuer's Common Stock reaching a specified price over a ten (10) consecutive trading day period at any time during the period commencing on February 18, 2025 and ending on July 30, 2029 (the "VWAP Achievement Period"), these performance based restricted stock units shall vest on the later of (x) July 30, 2025 and (y) the calendar day following the last day of the VWAP Achievement Period.
Footnote F7
These restricted stock units vest on the third anniversary of the grant date (April 11, 2025).
Footnote F8
These performance based restricted stock units have a three-year performance period and to the extent earned will vest on April 11, 2028. The number of shares of Common Stock that will be earned is subject to decrease based on the result of the performance condition.